
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | 2026-05-12 | TALWALKAR ABHIJIT Y | Director | Purchase | 5,312 | $10.71 | $57K | 25.6K | View ↗ | |
| 2026-05-11 | 2026-05-12 | TALWALKAR ABHIJIT Y | Director | Sale | 5,312 | $117.93 | $626K | 20.3K | View ↗ | |
| 2026-05-04 | 2026-05-05 | Lawrence Brian Lee | Chief Technology Officer | Sale | 1,014 | $120.80 | $122K | 20.2K | View ↗ | |
| 2026-03-16 | 2026-03-17 | Smith Mervin | EVP Strategic Business Ops | Sale | 2,585 | $114.30 | $295K | 23.0K | View ↗ | |
| 2026-03-02 | 2026-03-03 | Turakhia Minang | CHIEF MED/SCI OFCR EVP ADVTECH | Sale | 4,027 | $128.45 | $517K | 54.9K | View ↗ |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue, net | $747.1M+26.2% | $591.8M+20.1% | $492.7M+19.9% | $410.9M+27.3% | $322.8M |
| Cost of revenue | $219.9M+19.3% | $184.3M+14.6% | $160.9M+24.4% | $129.3M+18.3% | $109.3M |
| Gross profit | $527.3M+29.4% | $407.5M+22.8% | $331.8M+17.8% | $281.6M+31.9% | $213.6M |
| Research and development | $84.6M+18.4% | $71.5M+18.6% | $60.2M+29.3% | $46.6M+20.5% | $38.7M |
| Acquired in-process research and development | $3.0M-90.6% | $32.4M | $0 | $0 | — |
| Selling, general and administrative | $492.6M+17.7% | $418.6M+8.5% | $385.6M+19.7% | $322.2M+17.2% | $274.8M |
| Impairment charges | $4.5M+595.5% | $641K-94.2% | $11.1M | — | — |
| Total operating expenses | $584.7M+11.8% | $523.0M+14.5% | $457.0M+15.6% | $395.4M+26.1% | $313.5M |
| Loss from operations | -$57.4M+50.3% | -$115.5M+7.7% | -$125.2M-10.0% | -$113.8M-13.8% | -$99.9M |
| Interest income | $21.5M-1.9% | $21.9M+245.3% | $6.4M+170.3% | $2.4M | — |
| Interest expense | -$13.2M-2.6% | -$12.8M-251.3% | -$3.6M+11.8% | -$4.1M-254.0% | -$1.2M |
| Loss on extinguishment of debt | $0+100.0% | -$7.6M | $0 | $0 | — |
| Other income (expense), net | $5.4M+334.3% | $1.3M+732.8% | -$198K+36.9% | -$314K-366.1% | $118K |
| Total interest and other income (expense), net | $13.8M+396.5% | $2.8M+11.0% | $2.5M+219.2% | -$2.1M | — |
| Loss before income taxes | -$43.6M+61.3% | -$112.7M+8.1% | -$122.7M-5.8% | -$115.9M-14.7% | -$101.0M |
| Income tax provision | $953K+68.7% | $565K-24.7% | $750K+178.8% | $269K-26.7% | $367K |
| Net loss | -$44.6M+60.7% | -$113.3M+8.2% | -$123.4M-6.2% | -$116.2M-14.6% | -$101.4M |
| Net loss per common share, basic (in USD per share) | -$1K+61.7% | -$4K+10.1% | -$4K-4.1% | -$4K-12.1% | -$3K |
| Net loss per common share, diluted (in USD per share) | -$1K+61.7% | -$4K+10.1% | -$4K-4.1% | -$4K-12.1% | -$3K |
| Weighted-average shares, basic (in shares) | $32.0M+2.6% | $31.2M+2.2% | $30.5M+2.0% | $29.9M+2.0% | $29.3M |
| Weighted-average shares, diluted (in shares) | $32.0M+2.6% | $31.2M+2.2% | $30.5M+2.0% | $29.9M+2.0% | $29.3M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
3 of Wall Street’s Favorite Stocks on Our Watchlist
2 Small-Cap Stocks with Solid Fundamentals and 1 Facing Headwinds
iRhythm Holdings to Participate in Upcoming Investor Conferences
2 Oversold Stocks Set for a Comeback and 1 Facing Headwinds